Countries China
Kelun-Biotech's NDA for Sacituzumab Tirumotecan Accepted by China's NMPA Following Positive Lung Cancer Study Results
New drug application (NDA) for the core product sacituzumab tirumotecan (sac-TMT, formerly SKB264/MK-2870) based on the positive results from the pivotal O...
August 21, 2024 | News
CARsgen Therapeutics Completes Enrollment in Pivotal Phase II Trial of Satri-Cel for Advanced Gastric Cancer in China
CARsgen Therapeutics Holdings Limited , a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors...
August 20, 2024 | News
Astellas Pharma Gains NMPA Approval for PADCEV™ in China to Treat Advanced Urothelial Cancer
Astellas Pharma Inc. (TSE:4503, President and CEO: Naoki Okamura, "Astellas") announced that the Center for Drug Evaluation (CDE) of C...
August 20, 2024 | News
Vimgreen Pharmaceuticals Completes Enrollment for Phase 2 Trial of Novel A2A Receptor Antagonist in Parkinson's Disease
Vimgreen Pharmaceuticals, a science-driven pharmaceutical company focused on the modulation of adenosine signaling, announced the completion of enrollment ...
August 16, 2024 | News
Mabwell's Nectin-4 Targeting ADC Receives Breakthrough Therapy Designation in China for Urothelial Carcinoma
Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced its novel Nectin-4 targeting ADC (R&D code: 9MW2821)...
August 13, 2024 | News
MSD to Acquire Curon Biopharma’s Investigational Bispecific Antibody CN201 in $1.3 Billion Deal
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Curon Biopharmaceutical (Curon), a privately held biotechnology company, annou...
August 12, 2024 | News
Pioneering German Delegation, Led by Stem Cell Expert Prof. Mike Chan, Forges New Era of Sino-German Collaboration in Biotechnology
A landmark German delegation, led by world-renowned stem cell expert Prof. Dato' Sri Dr. Mike Chan, concluded a three-day visit to Baoding, China...
August 12, 2024 | News
WuXi Biologics and Medigene Forge Strategic Partnership to Advance TCR-Guided T Cell Engagers for Cancer Treatment
Partnership leverages Medigene's leadership for T cell receptor (TCR) generation and characterization and WuXi Biologics' unique anti-CD3 mAb, its T cell...
August 09, 2024 | News
Sanyou Bio and JiAnTeBo Forge Strategic Partnership to Innovate Metabolic Disease Therapies
Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. (hereinafter referred to as "Sanyou Bio") and Guangdong JiAnTeBo Biotechnology Co., Ltd. (hereinafter r...
August 08, 2024 | News
WuXi Biologics Secures EMA GMP Certification for Five Facilities in China
WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that four manufacturing facilities ...
August 02, 2024 | News
JelloX Biotech Collaborates with Mayo Clinic to Enhance 3D Digital Imaging and AI Analysis for Precision Cancer Diagnosis
JelloX Biotech Inc. ('JelloX') is pleased to announce that it has entered into a collaboration through a know-how agreement with Mayo Clinic to f...
August 01, 2024 | News
Akeso's Ivonescimab sBLA Accepted by NMPA for First-Line Treatment of PD-L1 Positive NSCLC
Akeso (9926.HK) is delighted to announce that the supplemental biologics license application (sBLA) for its independently developed, world's first-in-class...
July 30, 2024 | News
IASO Bio Receives Second FDA IND Approval in 2024 for Groundbreaking Cell Therapy Eque-cel to Treat Multiple Sclerosis
IASO Biotechnology ("IASO Bio"), a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing innovative cell therap...
July 25, 2024 | News
IVDCHINA 2024: Premier International Exhibition on In Vitro Diagnostics Set for August in Shanghai
The highly anticipated IVDCHINA 2024, an international exhibition and conference focused on the rapidly evolving field of in vitro diagnostics (IVD), is se...
July 22, 2024 | News
Most Read
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
